MoneyWorks4Me

A decrease in the sales to Rs. 284.42 millions was observed for the quarter ended December 2023. The sales stood at Rs. 342.18 millions during the similar quarter previous year.The Net Loss for the quarter ended December 2023 is Rs. -29.43 millions as compared to Net Profit of Rs. 29.95 millions of corresponding quarter ended December 2022Operating profit Margin for the quarter ended December 2023 slipped to -10.96% as compared to 49.69% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 284.42 342.18 -16.88 1110.67 731.06 51.93 1153.50 851.40 35.48
Other Income 9.79 19.27 -49.20 30.07 38.70 -22.30 32.73 16.98 92.76
PBIDT -10.96 49.69 -122.06 112.31 111.13 1.06 189.90 136.60 39.02
Interest 5.76 5.76 0.00 16.15 13.39 20.61 20.38 7.94 156.68
PBDT -16.72 43.93 -138.06 96.16 97.74 -1.62 169.52 107.10 58.28
Depreciation 12.71 13.98 -9.08 37.25 38.08 -2.18 53.34 54.93 -2.89
PBT -29.43 29.95 -198.26 58.91 59.66 -1.26 116.18 52.17 122.70
TAX 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -29.43 29.95 -198.26 58.91 59.66 -1.26 113.40 52.17 117.37
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) -3.85 14.52 -126.54 10.11 15.20 -33.48 16.46 16.04 2.61
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..